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Introduction
Different odontogenic cysts have variable clinical and 
biological behaviors. The odontogenic keratocyst (also termed 
as keratocystic odontogenic tumor), which occurs mainly in 
the mandibular posterior region, is an aggressive cystic lesion 
which has received special attention in the dental literature due 
to its high recurrence rate which ranges from 3% to 60%.[1] In 
contrast, the dentigerous cyst, which usually encloses the 
crown of an unerupted tooth, usually does not recur after 
adequate treatment. On account of their different biological 
behavior which necessitates different treatment approaches, it 
is very essential that a clear differentiation be made between 
the two lesions at the time of diagnosis. It has been proposed 
that specific properties of the cyst epithelium or supporting 
connective tissue, or both may explain the differences in the 
clinical behavior of the odontogenic keratocyst and other 
odontogenic cysts. Consequently, numerous attempts have 
been made to differentiate odontogenic keratocysts from 
dentigerous cysts by studying the patterns of expression of 
various molecular components, notably cytokeratins (CKs), 
by immunohistochemical methods.[2-6]
Cytokeratins that form the cytoskeleton of the epithelial cells 
are of several molecular types. The patterns of expression of 
these different types of CKs vary depending upon the type 
of epithelial cells and hence, they may be used as potential 
markers of cell differentiation and malignant transformation. 
CK 19, a type I (acidic) keratin, is the smallest keratin and is 
unique in that it lacks the carboxyterminal, non-α-helical tail 
domain, which is typical for all other keratins.[7] Although 
numerous investigators have studied the pattern of keratin 
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Background: Although numerous investigators have studied the pattern of keratin expression 
in different odontogenic cysts, the results have been variable. Aim: The present study 
was conducted to determine the pattern of expression of cytokeratin 19 (CK 19) in the 
epithelial lining of odontogenic keratocysts and dentigerous cysts. Materials and Methods: 
The epithelial layers showing expression of the epithelial marker CK 19 was determined by 
immunohistochemical methods in 15 tissue specimens each of histopathologically confirmed 
cases of dentigerous cysts and odontogenic keratocysts. Statistical analysis was done to 
compare the CK 19 expression between dentigerous cyst and odontogenic keratocyst using 
the Chi‑square test. P < 0.05 was considered to be statistically significant. Results: All 
specimens of dentigerous cysts were positive for CK 19 with 20% (3/15) of the specimens 
showing expression only in a single layer of the epithelium, 40% (6/15) of the specimens showing 
expression in more than one layer but not the entire thickness of the epithelium, and the 
remaining 40% (6/15) showing expression throughout the entire thickness of the epithelium. 
In the case of odontogenic keratocysts, 40% (6/15) of the specimens were negative for CK 
19, 40% (6/15) of the specimens showed expression only in a single layer of the epithelium, 
and 20% (3/15) of the specimens showed expression in more than one layer, but not the entire 
thickness of the epithelium. The observed differences in CK 19 expression by the two lesions 
were statistically significant (P < 0.01). Conclusion: The differences in CK 19 expression by 
these cysts may be utilized as a diagnostic tool in differentiating between these two lesions.
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expression in different odontogenic cysts, the results have been 
variable.[8-12] Gao et al.[8] studied the patterns of expression 
of different CK in dentigerous cysts and keratocysts and 
reported that CK 19 stained with either the full thickness of 
the epithelial lining or with only the superficial cell in the 
dentigerous cysts while it stained suprabasal cells and some 
basal cells in odontogenic keratocysts. They also reported that 
while CK 4 and CK 13 stained the suprabasal cells of both 
dentigerous and odontogenic keratocysts, CK 16 reacted only 
weakly and patchily with suprabasal cells in some dentigerous 
cysts while it stained strongly with the suprabasal cells of 
all odontogenic keratocysts. Another study by Hormia et al. 
reported that antibodies to CK 19 reacted with the basal 
and parabasal cells and antibodies to CK 13 and 16 reacted 
with the suprabasal cells in odontogenic kertatocyts while 
they showed heterogenous positivity in dentigerous cysts.[10] 
While antibodies to CK 18 did not stain any of the cells in 
odontogenic keratocysts, dentigerous cysts showed a distinct 
layer of cells positive to CK 18. Stoll et al. reported that 
while greater proportion of odontogenic keratocysts in their 
study showed expression of CK 17 compared to dentigerous 
cysts, CK 19 expression was not demonstrated in any of the 
odontogenic keratocysts while it was present in around 50% 
of the dentigerous cysts.[2] On account of these variations in 
the results reported by different investigators, the present 
study was conducted to determine the pattern of expression 
of CK 19 in the epithelial lining of odontogenic keratocysts 
and dentigerous cysts.
Materials and Methods
The present study was conducted as a retrospective study 
utilizing tissue specimens from the archives of the Department 
of Oral Pathology, Yenepoya Dental College, Mangalore, 
Karnataka State, India during the period July 2008 to January 
2009. Fifteen tissue specimens each of histopathologically 
confirmed cases of dentigerous cysts, as well as odontogenic 
keratocysts (nonsyndromic), were utilized for the purpose of 
the study. No formal power analysis was done in calculating 
the sample size, and a convenience sampling technique was 
followed. Tissue specimens that were smaller than 3 mm in 
size were not considered for the study purpose. The study 
protocol was approved by the Institutional Ethics Committee 
of Yenepoya Dental College.
The cytoplasmic expression of the epithelial marker 
CK 19 in the lining epithelium of dentigerous cysts 
and odontogenic keratocysts  was determined by 
immunohistochemical staining in which Super Sensitive 
Multilink-Horseradish Peroxidase (HRP) Detection 
Kit/Diaminobenzidine (DAB) (BioGenex Laboratories Inc., 
San Ramon, California, USA) was used for determining the 
expression of CK 19 in the tissue specimens. Tissue sections 
of 3–4 μm thickness were obtained by cutting the tissue blocks 
over rotary microtome (LEICA RM; Leica Microsystems 
Inc., Buffalo Grove, Illinois, USA) and mounted on to 
3-aminopropyltriethoxysilane coated slides. The sections were 
deparaffinized with xylene, rehydrated in grades of alcohol, 
and washed in distilled water.
Antigen retrieval was performed by treatment with the enzyme 
pepsin at a temperature of 35–40°C for 12 min. The pepsin 
solution for the antigen retrieval was prepared according to 
the recommendation of the manufacturer by dissolving 800 mg 
of pepsin powder in 40 ml of distilled water and adjusting the 
pH to 2.5 with 1 N HCl.
After antigen retrieval, the tissue sections were rinsed first 
in distilled water and then with Tris buffer, followed by 
treatment with peroxidase block (3% hydrogen peroxide) 
for 15 min to block endogenous peroxidase activity. The 
slides were then placed in a humid chamber. After this, 
the slides were drained and rinsed in two changes of Tris 
buffer (wash buffer), each of 5 min duration. Nonspecific 
protein–protein interactions were blocked by treating 
and incubating the tissue sections with the power block 
(casein in phosphate buffered saline) for 10 min duration 
in a humid chamber. After this, the remaining solution was 
drained from the slides. The sections were then incubated in 
the prediluted primary antibody (CK 19) at room temperature 
in the humid chamber for 90–120 min. The primary antibody 
provided by the manufacturer was mouse monoclonal 
antibody (class IgG1 kappa, clone RCK108) to CK 19 from 
ascites and reacts with the 40 kDa protein corresponding 
to human CK 19. Again, the remaining solution was 
drained from the slides and rinsed in two changes of Tris 
buffer (washing buffer) as mentioned earlier. Sections were 
then treated with a reagent for enhancing the staining for 
30 min, followed by rinse in two changes of Tris buffer. 
Sections were then incubated with multilink secondary 
antibody solution (biotinylated anti-immunoglobulins) for 
30 min. This was followed by rinsing with wash buffer and 
treatment with HRP label (HRP-conjugated streptavidin) for 
30 min. Subsequently, the sections were treated with DAB 
chromogen/substrate 3,3-DAB chromogen/H2O2/substrate 
buffer solution (1 ml of DAB buffer mixed with 1 drop of 
DAB chromogen in the mixing vial and allowed to stand 
for about 10 min), covered with drops of chromogen DAB 
buffer solution, and allowed to stand in the humid chamber 
for 8–10 min. During this period, brown staining was visible 
with varying intensity on different sections. Then the slides 
were rinsed first in distilled water followed by running tap 
water. The sections were then counterstained with Harris 
hematoxylin solution for 20 s, rinsed in running tap water, 
and dehydrated and mounted with dibutyl phthalate and 
xylene. Colon carcinoma tissue sections were used as 
positive controls while specimens that were treated as above 
except for the fact that the primary antibody was omitted 
were used as negative controls.
The 30 stained slides were evaluated under the bright field 
(LABOMED; Labomed, Inc., Los Angeles, California, USA) 
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at 100‑ and 200‑fold magnification. The extent of cytoplasmic 
staining was graded as follows:
• ‘+’ ‑ Single layer of the lining epithelium is stained
• ‘++’ ‑ More than one layer of the lining epithelium is 
stained, but not the entire thickness
• ‘+++’ ‑ Entire thickness of the lining epithelium is stained.
The tissue sections which did not express CK 19 were 
considered as negative in pattern of staining. Photomicrographs 
were taken with Olympus SP-350 camera (Olympus Imaging 
America Inc., Center Valley, Pennsylvania, United States).
Statistical analysis was performed to compare the CK 19 
expression between dentigerous cyst and odontogenic 
keratocyst using the Chi-square test. Statistical analyses 
were performed using software for statistical analysis 
(SPSS software version 17, IBM Corporation, Armonk, 
New York, USA). P < 0.05 was considered as statistically 
significant.
Results
The number of specimens of dentigerous cysts and odontogenic 
cysts showing different patterns of staining is shown in Table 1. 
Among the 15 specimens of dentigerous cysts, 20% (3/15) 
showed ‘+’, 40% (6/15) showed ‘++’, and 40% (6/15) showed 
‘+++’ expression [Figure 1] of the CK 19. The specimens that 
showed ‘+’ and ‘++’ staining showed staining of mainly the 
superficial and supra basal cells. Regarding the odontogenic 
keratocysts, among the 15 specimens, 40% (6/15) showed 
’+’ [Figure 2], 20% (3/15) showed ‘++’, and 40% (6/15) 
were negative [Figure 3] for the expression of CK 19. The 
CK 19 positive specimens showed staining of mainly the 
superficial layer of epithelial cells. The observed differences 
in the pattern of vertical extent of CK 19 expression 
between dentigerous cysts and odontogenic keratocysts were 
statistically significant (P < 0.01).
Discussion
On account of the differences in the clinical behavior such as 
chances of recurrence of the dentigerous cysts and odontogenic 
keratocysts, it is very important that a clear differentiation 
may be made between the two entities. Since these lesions 
arise from odontogenic epithelium and may have a similarity 
in the radiographic and histological appearance, numerous 
attempts have been made to differentiate these two lesions by 
immunohistochemical methods targeting various molecules 
including CKs.
Several studies have been carried out by different researchers to 
determine if particular patterns of CKs would serve as accurate 
Table 1: Patterns of cytokeratin 19 expression in dentigerous 
cysts and odontogenic keratocysts










Dentigerous cyst 20 (3) 40 (6) 40 (6) 0 100 (15)
Odontogenic keratocysts 40 (6) 20 (3) 0 40 (6) 100 (15)
P<0.01. ‘+’: Single layer of lining epithelium is stained, ‘++’: More than one layer of 
lining epithelium is stained but not the entire thickness, ‘+++’: Entire thickness of lining 
epithelium is stained
Figure 1: Expression of cytokeratin 19 (indicated by arrows) in the entire 
thickness of the epithelium of dentigerous cyst (×100 magnification)
Figure 2: Expression of cytokeratin 19 (indicated by arrows) in 
only a single layer of the epithelium of odontogenic keratocyst 
(×200 magnification)
Figure 3: Negative expression of cytokeratin 19 in odontogenic 
keratocyst (×100 magnification)
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diagnostic markers for the odontogenic keratocysts and the 
dentigerous cysts. The various CKs that have been studied 
include CK 4, 5, 6, 7, 8, 10, 13, 14, 16, 17, 18, 19, and 20.[2,8,10,11]
In the present study, the pattern of expression of CK 19 in 
odontogenic keratocysts and dentigerous cysts was studied 
immunohistochemically, and it was observed that CK 19 
expression was more pronounced in dentigerous cysts than in 
odontogenic keratocysts. CK 19, the smallest known acidic 
type CK, is expressed in human tissues without association 
with a basic CK.[7] Usually expressed in the basal cells of 
nonkeratinizing stratified squamous epithelia,[13] CK 19 
expression has been reported to occur in the suprabasal cells 
of oral stratified squamous epithelium in association with 
inflammation and epithelial dysplasia.[14,15] CK 19 expression 
in various pathologic conditions has been studied previously. 
CK 19 expression has been associated with poor differentiation 
and aggressive behavior of hepatocellular carcinomas[16] and 
has been used for differentiating hepatocellular carcinoma from 
adenocarcinoma.[13] CK 19 expression has also been reported to 
be higher in malignant neoplasms of the thyroid compared to 
benign nodules.[17] Detection of soluble fragments of CK 19 in 
the serum has been used as a marker for monitoring treatment 
and response to therapy of squamous cell carcinoma[13] and it 
has been demonstrated that tumor cells in breast cancer patients 
can release full-length CK 19 and this is associated with high 
metastatic properties.[18] Detection of high levels of fecal CK 
19 mRNA has also been suggested as a potential marker for 
colorectal malignancy.[19] CK 19 expression has been reported 
to be reduced in oral submucous fibrosis compared to healthy 
mucosa and CK 19 gene is one of the genes with decreased 
expression in oral submucous fibrosis.[20]
The pattern of expression of CK 19 in odontogenic keratocysts 
and dentigerous cysts has been previously investigated. 
Hormia et al., in their study with immunohistochemical 
staining of odontogenic keratocysts and dentigerous cysts 
for CK 19 showed that the basal and few suprabasal cells of 
odontogenic keratocysts showed positive expression whereas, 
in the case of dentigerous cysts, the antibody to CK 19 showed 
heterogeneous positivity with the staining pattern varying 
between different samples, within the same sample and 
between the cells.[10] Gao et al., in their study, reported that 
the antibody to CK 19 reacted with either the full thickness 
of the epithelium or only the superficial cells in the case of 
dentigerous cysts and with the supra basal cells and some 
basal cells in the case of odontogenic keratocysts.[8] In a recent 
study, Stoll et al. reported that CK 19 expression was positive 
in only 50% of their 30 cases of dentigerous cysts with eight 
cases showing superficial expression while all the cases of 
odontogenic keratocysts were negative for CK 19.[2]
In the present study, 40% of the dentigerous cysts showed 
staining in all the layers of the lining epithelium while the 
remaining cases showed only partial staining. These results 
were similar to that of Gao et al.[8] but differed from that of 
Stoll et al.[2] in that all cases of dentigerous cysts were positive 
for CK 19. The pattern of CK 19 staining in dentigerous cysts 
in the present study were similar to that reported by Gao 
et al.[8] in that the specimens showed CK 19 staining either 
in the full thickness of the epithelium or in the superficial 
layers. CK 19 expression confined to the superficial layers of 
dentigerous cysts was also reported by Stoll et al. in eight of 
their 15 specimens of dentigerous cysts positive for CK 19.[2] 
In relation to odontogenic keratocysts, the 40% of the cases in 
the present study were negative for CK 19 while 60% showed 
positive staining in only few layers. This is different from 
that reported by Stoll et al.[2] where all cases of odontogenic 
keratocysts were negative. The staining pattern in which only 
a few layers showed expression for CK 19 is similar to that 
reported by Hormia et al.[10] and Gao et al.[8] However, the 
layers in which the staining was observed differed from that 
reported in some of the earlier studies. The staining of CK 19 in 
odontogenic keratocysts in the present study was mainly seen 
in the suprabasal layers and this pattern, although similar to 
that reported by Gao et al.,[8] was different from that reported 
by Hormia et al.,[10] where the odontogenic keratocysts had 
shown a positive staining for CK 19 mainly in the basal and 
parabasal layer of cells. However, it is to be understood that 
interpretation of CK staining is subjective depending on the 
evaluation by the individual pathologists. Moreover, CK 19 
is only one of the several molecular markers, which may be 
beneficial in differentiating between the various odontogenic 
lesions. Hence, further investigations with a larger sample size 
to study the pattern of expression of other epithelial markers 
may also be beneficial in providing additional diagnostic 
parameters for the easy differentiation between the two lesions.
To conclude, the findings of the present study indicate and 
support the findings from some earlier studies that significant 
differences exist in the expression of CK 19 between the 
dentigerous cyst and odontogenic keratocyst, and these 
differences in CK 19 expression by these cysts may be utilized 
as an additional diagnostic tool in differentiating between these 
two lesions. However, it is to be understood that interpretation 
of CK staining is subjective depending on the evaluation by 
the individual pathologists. Moreover, CK 19 is only one 
of the several molecular markers, which may be beneficial 
in differentiating between the various odontogenic lesions. 
Hence, further investigations with a larger sample size to study 
the pattern of expression of other epithelial markers may also 
be beneficial in providing additional diagnostic parameters for 
the easy differentiation between the two lesions.
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